UNSPSC 85501935: Bypass right subclavian artery to left upper arm artery with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass right subclavian artery to left upper arm artery with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03130K1

UNSPSC 85501935 Bypass right subclavian artery to left upper arm artery with nonautologous tissue substitute, open approach is a Commodity code that nominally describes a specific surgical procedure, but recent state and local procurement activity under this code shows little alignment with its clinical name. The recent opportunities tagged to this code encompass medical surveillance, independent medical evaluations, pharmacy benefit management, health professional staffing, and surgical carve-out benefit administration — none of which describe the bypass procedure the code ostensibly names. The issuing bodies include city retirement offices, county health systems, state departments of transportation, and county commissioners' offices, reflecting a broad mix of municipal and state healthcare purchasing.

Activity appears scattered across Arizona, California, Florida, and Washington, with no clear geographic concentration. Recent opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026, maximum contract compensation $750,000 over five years); the Washington State Department of Transportation's RFP for occupational medical surveillance services across 14 Washington ferry locations (RFP20260825, due October 9, 2026); the City of Long Beach's RFP for surgical benefit carve-out programs through Centers of Excellence (HR26753, due October 7, 2026); and Collier County's RFP for Pharmacy Benefit Management Services (RFP 25-8414, due April 9, 2026, historical annual pharmacy spending approximately $8.7 million). The code's recent activity suggests procurement classification misalignment rather than sustained demand for the specific surgical procedure the code describes.